ArticleCureus2025
Recognizing Synchronous Multiple Primary Lung Cancer: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary nodules are frequently identified on radiographic evaluation, often due to lung cancer screening with low-dose computed tomography, an increasingly utilized technology in high-risk patients, or incidentally discovered with alternative imaging modalities. Although most nodules are benign, lung cancer remains difficult to treat, particularly in its late stages, which are more prone to metastasis. We present a case of a 71-year-old female, a former smoker, who was evaluated in the emergency department for chronic cough and dyspnea. On evaluation, computed tomography pulmonary angiography incidentally revealed three distinct pulmonary nodules. Following evaluation by our multidisciplinary team, robot-assisted bronchoscopy (RAB) was performed, revealing three distinct primary malignancies: well-differentiated adenocarcinoma with KRAS mutation, poorly differentiated adenocarcinoma with EGFR mutation, and a well-differentiated carcinoid tumor. The patient underwent staged surgical resections for curative intent. This case underscores the limitations of strict adherence to existing pulmonary nodule guidelines, such as those from the Fleischner Society, which, in this instance, could have led to inaccurate staging and palliative systemic therapy. It also highlights the critical value of considering biopsy of multiple nodules, now increasingly feasible with advanced technologies such as RAB. Early and accurate characterization of each lesion allowed for appropriate staging and individualized, potentially curative treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.